Detecting Malingering Detection Using Eye Movements and Response Time (MDER)

NCT ID: NCT03201887

Last Updated: 2017-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-01

Study Completion Date

2019-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Performance Validity Tests (PVTs) are widely used for the detection of sub-optimal effort and malingering in neuropsychological assessments. Threats to their validity however likely to intensify with time (e.g., information available on the web or from legal representatives) and may lead to a decline in their ability to differentiate between malingerers and non-malingerers. Eye movements and response time (RT) are less obvious outcome measures and under less conscious control than more conventional PVT indices (e.g., accuracy). They are therefore promising measures that can aid in detecting malingering when used in conjunction with more conventional PVT indices. The Word Memory Test (WMT) is a widely used PVT in neuropsychological evaluations. As part of the proposed study, TBI patients, chronic pain patients and healthy adults (60 in each group) will be randomly divided to one of two conditions; optimal effort or sub-optimal effort (participants will be asked to play a TBI patient who wishes to present himself as having cognitive deficits or exaggerate existing cognitive deficits). The proposed study will improve the WMT's efficacy in detection of sub-optimal effort in neuropsychological evaluations and therefore protect its validity from future threats. In addition, the proposed study will provide us with better understanding of the effect of TBI on eye movements and RTs in general.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Same as in the brief summary

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Damage Chronic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sub-optimal Traumatic Brain Injury

Sub-optimal effort

Group Type EXPERIMENTAL

Sub-optimal effort

Intervention Type BEHAVIORAL

Participants will be asked to play a patient who wishes to present himself as having cognitive deficits or exaggerate existing cognitive deficits

optimal effort

Intervention Type BEHAVIORAL

Participants will be asked to perform tasks to the best of their abilities.

Sub-optimal effort Chronic pain

Sub-optimal effort

Group Type EXPERIMENTAL

Sub-optimal effort

Intervention Type BEHAVIORAL

Participants will be asked to play a patient who wishes to present himself as having cognitive deficits or exaggerate existing cognitive deficits

optimal effort

Intervention Type BEHAVIORAL

Participants will be asked to perform tasks to the best of their abilities.

Traumatic Brain Injury

optimal effort

Group Type NO_INTERVENTION

No interventions assigned to this group

Chronic pain

optimal effort

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sub-optimal effort

Participants will be asked to play a patient who wishes to present himself as having cognitive deficits or exaggerate existing cognitive deficits

Intervention Type BEHAVIORAL

optimal effort

Participants will be asked to perform tasks to the best of their abilities.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Simulation condition control condition

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (18-65) female and males.
* Signed informed consent form.


* TBI of at least mild severity, as operationalized by Post traumatic amnesia (PTA) \< 24 hours
* Glasgow coma scale (GCS) of 13-15
* Loss of consciousness (LOC) of 30 minutes or less.


• Pain without apparent biological value that has persisted beyond three months. This will be based on the participant self-report, electronic medical records and consultation with treating physician.

Exclusion Criteria

* Any current eye impairment (e.g., limited visual field, nystagmus, astigmatism \[cylinder\], strabismus or any other impairment specified by the participant), past strabismus, and refractive surgery.
* Significant past neurological disorder/s and/or neurosurgery (special emphasis will be put on any language impairment such as aphasia).
* Significant developmental disorders (e.g., learning disabilities such as dyslexia). (d)
* Significant past or present psychiatric disorders (as evident, for example, in psychiatric inpatient hospitalization and past suicide attempts).
* Exclusion according to the last three articles (a-c) will be decided by a joint consultation of the research team.
* Any condition of chronic pain (see criteria in the inclusion for the chronic pain group).
* Significant current neurological disorder/s (special emphasis will be put on any language impairment such as aphasia) as decided by a joint consultation of the research team.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ariel University

OTHER

Sponsor Role collaborator

Loewenstein Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Moti Ratmansky, MD

Role: PRINCIPAL_INVESTIGATOR

Loewenstein Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Moti Ratmansky, MD

Role: CONTACT

972-9-7709140

Yoram Braw, PHD

Role: CONTACT

972-54-8132604

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Tasmc16ys0ctil

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effectiveness of VestAid App
NCT06683417 NOT_YET_RECRUITING NA